Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Methods and devices for rapid and specific detection of multiple proteins
Method and apparatus for reducing power consumption used in communication system having time slots
Systems and methods for documenting medical findings of a physical examination
Stable liquid VEGF antagonist formulations
Optical analysis device, optical analysis method and computer program for optical analysis
Clamp for fence panels
Method for forming contact hole
  Randomly Featured Patents
WVT design for reduced mass and improved sealing reliability
Reactive matrix for removing moisture from a fluorine containing gas and process
Cable tensioning device
Surveying of boreholes
Transferring, processing and displaying multiple images using single transfer request
Fusion fixing apparatus employing heat and pressure
Thermalization using optical components in a lens system
Hole punch for a ring-binder
Folding box with a subdivided interior